Neoplasms: all 9,617 studies

Page 52 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid TumoursCompletedNCT04914351Phase 1
• A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid TumorsCompletedNCT04914286Phase 1/2
• A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid TumoursCompletedNCT04914117Phase 1
• IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors.CompletedNCT04912466Phase 1
• A Study of Dose Escalation of IBI321 in Patients With Advanced Solid TumorsCompletedNCT04911894Phase 1
• A Study of the Safety and Tolerability of IBI321 in Patients With Advanced Solid TumorsCompletedNCT04911881Phase 1
• Depth of Necrosis in Normal Cervical Epithelium After 85% Trichloroacetic Acid (TCA) ApplicationCompletedNCT04911075Not applicable
• Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor SurvivorsStatus unknownNCT04909307
• A Drug-drug Interaction Study of Avapritinib and MidazolamCompletedNCT04908176Phase 1
• A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1SuspendedNCT04908111Phase 1/2
• A Study of HMPL-295S1 in Patients With Advanced Malignant Solid TumorsCompletedNCT04908046Phase 1
• Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid TumorsStatus unknownNCT04906473Phase 1
• Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerActive, not recruitingNCT04906395Phase 3
• Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 MutationsStatus unknownNCT04906031Phase 2
• A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer PopulationsStatus unknownNCT04905329
• Effectiveness of the SpaceOAR Vue System in Subjects With Prostate CancerActive, not recruitingNCT04905069Not applicable
• HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
• Cultivating Resilience in Oncology PracticeCompletedNCT04902313Phase 1
• Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid TumorsTerminatedNCT04901806Phase 1
• Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN)Status unknownNCT04901364
• Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid TumorsStatus unknownNCT04900519Phase 1
• Feasibility Study of a 4 Stage Bowel Obstruction Cancer DietCompletedNCT04898842Not applicable
• A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRTTerminatedNCT04897880Phase 2
• Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)Status unknownNCT04892498Phase 2
• Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsTerminatedNCT04892043Phase 1
• A Phase I Study of BR790 in Subjects With Advanced Solid TumorsStatus unknownNCT04891653Phase 1
• A Phase I Study of AL8326 in Advanced Solid TumorStatus unknownNCT04890587Phase 1
• A Bioequivalence Study of Docetaxel Injection in Patients With Solid TumoursCompletedNCT04889599Phase 3
• A Study of DT2216 in Relapsed/Refractory MalignanciesCompletedNCT04886622Phase 1
• A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent CancerStatus unknownNCT04881981Phase 1
• Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy NeedleStatus unknownNCT04880681Not applicable
• A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid MalignanciesTerminatedNCT04880564Phase 1/2
• Immunogenicity of Covid-19 Vaccination for Patients With Hematological MalignanciesStatus unknownNCT04878822
• Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer TherapiesStatus unknownNCT04878692Not applicable
• Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid TumorsWithdrawnNCT04878484Phase 1
• TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)TerminatedNCT04873895Phase 1
• The Safety and Efficacy of TWP-101 in Patients With Advanced Solid TumorStatus unknownNCT04871347Phase 1
• Study of Attention and Memory Treatments for Cancer SurvivorsCompletedNCT04870320Not applicable
• Study of AK112 in the Treatment of Advanced Gynecological TumorsCompletedNCT04870177Phase 2
• Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 MutationStatus unknownNCT04869475Phase 2
• Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative CareCompletedNCT04867122Not applicable
• A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04866134Phase 1/2
• Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.TerminatedNCT04866056Phase 1/2
• Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid MalignanciesTerminatedNCT04865159Phase 1
• (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
• TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid TumorCompletedNCT04862767Phase 1
• Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT04862260Early Phase 1
• Validation of the GMFM-88 Scale and of the FAAP-O Scale in Pediatric Patients Affected by CancerCompletedNCT04862130
• A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract TumorsCompletedNCT04861987Phase 1
• A Study of HSK29116 in Adults With Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04861779Phase 1
• Transfusional Trigger in Post-operative Oncologic Patients in Critical CareStatus unknownNCT04859855Not applicable
• A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid TumorsStatus unknownNCT04859777Phase 1
• Pediatric Prospective Personalized Immune and Target Identification TrialCompletedNCT04859543Not applicable
• A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid TumorsCompletedNCT04857138Phase 1
• Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid TumorsCompletedNCT04856774Phase 1/2
• Role of Gray Scale and Color Doppler Ultrasound in Diagnosis of Pediatric Neck MassesStatus unknownNCT04856020
• Phase 1 Trial of the TQB2928 Injection in Patients With Advanced CancersStatus unknownNCT04854681Phase 1
• 68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)No longer availableNCT04854369
• A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLCTerminatedNCT04849273Phase 1
• Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck CancerCompletedNCT04847466Phase 2
• A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid TumorsStatus unknownNCT04843033Phase 1
• Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery.Status unknownNCT04842994Not applicable
• A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid TumorsTerminatedNCT04842630Phase 1
• Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid TumorsStatus unknownNCT04841421Early Phase 1
• Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsCompletedNCT04840394Phase 1
• A Study to Evaluate Visually Inspired Patient Education Material on Willingness to Pursue Radiation TherapyTerminatedNCT04839679Not applicable
• AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer MalignanciesCompletedNCT04835675
• Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of TreatmentStatus unknownNCT04834570
• To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.CompletedNCT04831944Phase 1
• 68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalStatus unknownNCT04831307Not applicable
• A Tailored Exercise Oncology Program for Neuro-Oncology PatientsStatus unknownNCT04831190Not applicable
• Aberrant DNA Methylation to Predict Metachronous Gastric NeoplasmsCompletedNCT04830618
• Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid TumorsCompletedNCT04830501Phase 1
• Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)CompletedNCT04826523
• Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in OncohematologyCompletedNCT04826458Not applicable
• A Phase Ib Study of HX008 in Patients With Advanced Solid TumorsStatus unknownNCT04825392Phase 1
• A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)TerminatedNCT04824859Not applicable
• Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19CompletedNCT04824443Phase 1
• VR for Symptom Control and WellbeingCompletedNCT04821466Not applicable
• Perception of Cure Among Patients With Metastatic CancerWithdrawnNCT04820894
• BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid TumorsCompletedNCT04819373Phase 2
• A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With LarotrectinibCompletedNCT04814667
• VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal CancerCompletedNCT04813913Phase 4
• CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and BloodActive, not recruitingNCT04811846Not applicable
• Gastrointestinal Anastomosis Using MonoPlus® SutureWithdrawnNCT04811833
• DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Evaluate Efficacy and saFEty in patieNts With soliD tumORsStatus unknownNCT04811443
• Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid TumoursTerminatedNCT04810208Phase 1
• Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid TumorsWithdrawnNCT04809012Phase 2
• Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerActive, not recruitingNCT04807166Phase 2
• Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal TissuesStatus unknownNCT04804410Not applicable
• Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM StudyWithdrawnNCT04803630Early Phase 1
• Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial TrialActive, not recruitingNCT04803604Not applicable
• Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto IStatus unknownNCT04803188Not applicable
• A Study of HB002.1T Plus Chemotherapy in Subjects With Solid TumorStatus unknownNCT04802980Phase 1
• Full-thickness Laparo-endoscopic Excision vs Laparoscopic Colectomy for Colonic TumorsStatus unknownNCT04801355Not applicable
• Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain MetastasesStatus unknownNCT04801342Phase 2
• Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWithdrawnNCT04799431Phase 1
• Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionCompletedNCT04799080
• A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid TumorWithdrawnNCT04797468Phase 1
• Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.Active, not recruitingNCT04795661Phase 2

← Neoplasms overview